Business Services Industry
Drug's heart attack risk findings 'flawed'.
Australasian Business Intelligence, June, 2009
Byline: Kate Hagan
Jun 22, 2009 (The Age - ABIX via COMTEX) -- Pharmaceutical company, Merck, has argued that conclusions about the risk of anti-arthritis drug Vioxx were flawed. Cardiologists told the Federal Court that the risk of the lead claimant having a heart attack was doubled by taking Vioxx. Merck's lawyer said that this ignored the claimant's other significant risk factors.
Publication Date: 23 June 2009
MERCK AND COMPANY INCORPORATED MERCK SHARP AND DOHME (AUSTRALIA) PTY LTD FEDERAL COURT OF APPEAL (CANADA)
Copyright 2009 LexisNexis Australia. All Rights Reserved.
**********************************************************************
As of Thursday, 06-18-2009 23:59, the latest Comtex SmarTrend[R]...
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
